molecular

In the fight against cancer, a new tool has emerged that’s shifted the treatment landscape. CAR T-cell therapy, first approved for clinical use in 2017, uses a patient’s own re-engineered immune cells to attack cancer. It has proven to be particularly effective against certain types of lymphoma. Its success represents […]